Our results showed that tumour cell proliferation, as clarified by Ki67 immunolabelling, was significantly lower in HCC mice receiving SO, MBZ or the combination of both than in DEN-only mice. This evidence concerns the gene MKI67 and hepatocellular carcinoma.